Free Trial

Heartflow (HTFL) 10K Form and Latest SEC Filings 2026

Heartflow logo
$28.32 -3.92 (-12.16%)
Closing price 04:00 PM Eastern
Extended Trading
$28.26 -0.06 (-0.21%)
As of 04:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Latest Heartflow SEC Filings & Recent Activity

Heartflow (NASDAQ:HTFL) has submitted 84+ documents to the U.S. Securities and Exchange Commission (SEC) since 2017. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. Key figures from these filings, including revenue, earnings, and cash flow, are summarized in Heartflow's financial statements. The most recent filing was a Form 10-Q submitted on May 14, 2026.

Form 4
Heartflow, Inc. Reports Ownership Change on May. 13, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

10-Q
Heartflow Files Quarterly Report on May. 14, 2026

The 10-Q contains Heartflow's unaudited quarterly financial statements, revenue, earnings updates, and cash flow changes between annual reports.

View earnings history

Heartflow SEC Filing History

Browse Heartflow's complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
05/14/2026 3:31 PM
Heartflow (1464521) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/13/2026 5:23 PM
Farquhar John C.M. (1900415) Reporting
Heartflow (1464521) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2026 2:04 PM
Hayfin Special Opportunities Fund II LP (1666853) Filed by
Heartflow (1464521) Subject
Form SCHEDULE 13G/A
05/11/2026 9:20 AM
Farquhar John C.M. (1900415) Reporting
Heartflow (1464521) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/08/2026 5:42 PM
Farquhar John C.M. (1900415) Reporting
Heartflow (1464521) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2026 5:44 PM
Heartflow (1464521) Issuer
Verghese Vikram (2079946) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2026 5:45 PM
Heartflow (1464521) Issuer
Rogers Campbell (1585724) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2026 5:47 PM
Heartflow (1464521) Issuer
Jones Marie L. (1968991) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2026 7:46 PM
Bain Capital Life Sciences Fund III, L.P. (1875273) Reporting
Bain Capital Life Sciences III General Partner, LLC (1952106) Reporting
Bain Capital Life Sciences Investors, LLC (1703031) Reporting
BCLS Fund III Investments GP, LLC (1952080) Reporting
BCLS Fund III Investments, LP (1952107) Reporting
Heartflow (1464521) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2026 8:11 AM
Heartflow (1464521) Filer
Form ARS
04/29/2026 8:00 AM
Heartflow (1464521) Filer
Form DEF 14A
04/29/2026 8:05 AM
Heartflow (1464521) Filer
Form DEFA14A
04/14/2026 4:53 PM
Farquhar John C.M. (1900415) Reporting
Heartflow (1464521) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2026 10:03 AM
Farquhar John C.M. (1900415) Reporting
Heartflow (1464521) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/03/2026 5:15 PM
Heartflow (1464521) Issuer
Rogers Campbell (1585724) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2026 3:23 PM
Heartflow (1464521) Subject
Rogers Campbell (1585724) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/31/2026 4:42 PM
HealthCor Partners Management LP (1519462) Filed by
Heartflow (1464521) Subject
Form SCHEDULE 13G
03/26/2026 4:45 PM
Heartflow (1464521) Issuer
Lightcap Jeffrey C (1519465) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2026 12:04 PM
HealthCor Partners Management LP (1519462) Reporting
Heartflow (1464521) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2026 5:33 PM
Heartflow (1464521) Issuer
Rogers Campbell (1585724) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2026 5:24 PM
Farquhar John C.M. (1900415) Reporting
Heartflow (1464521) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2026 3:25 PM
Heartflow (1464521) Filer
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/18/2026 1:17 PM
Farquhar John C.M. (1900415) Reporting
Heartflow (1464521) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/12/2026 6:55 PM
Farquhar John C.M. (1900415) Reporting
Heartflow (1464521) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2026 6:57 PM
BARABE TIMOTHY C (1237409) Reporting
Heartflow (1464521) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2026 9:53 AM
Farquhar John C.M. (1900415) Reporting
Heartflow (1464521) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/06/2026 7:18 PM
Cullivan Julie A (1713207) Reporting
Heartflow (1464521) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2026 3:23 PM
Heartflow (1464521) Subject
WELLINGTON MANAGEMENT GROUP LLP (902219) Filed by
Form SCHEDULE 13G/A
03/05/2026 1:11 PM
Cullivan Julie A (1713207) Reporting
Heartflow (1464521) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/19/2026 6:14 PM
BARABE TIMOTHY C (1237409) Reporting
Heartflow (1464521) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2026 7:07 PM
Heartflow (1464521) Issuer
Rogers Campbell (1585724) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2026 3:45 PM
Heartflow (1464521) Subject
Rogers Campbell (1585724) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/10/2026 7:55 PM
Heartflow (1464521) Issuer
Jones Marie L. (1968991) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2026 7:18 PM
Heartflow (1464521) Issuer
Verghese Vikram (2079946) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2026 7:21 PM
Heartflow (1464521) Issuer
Rogers Campbell (1585724) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2026 7:24 PM
Farquhar John C.M. (1900415) Reporting
Heartflow (1464521) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2026 3:12 PM
Farquhar John C.M. (1900415) Reporting
Heartflow (1464521) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/10/2026 10:21 AM
Heartflow (1464521) Subject
WELLINGTON MANAGEMENT GROUP LLP (902219) Filed by
Form SCHEDULE 13G/A
02/06/2026 8:42 PM
Cullivan Julie A (1713207) Reporting
Heartflow (1464521) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2026 8:58 AM
Cullivan Julie A (1713207) Reporting
Heartflow (1464521) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/12/2026 7:30 AM
Heartflow (1464521) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
The Iran War Just Broke the Gold Market (Ad)

The Iran war isn't just a geopolitical event. It's a financial one. Within hours of the strikes, oil surged… Defense stocks exploded…And gold ripped past $5,000.tc pixel

You can see the evidence — and the ticker symbol — here >>>
12/17/2025 5:43 PM
Heartflow (1464521) Issuer
Lightcap Jeffrey C (1519465) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/24/2025 2:34 PM
HealthCor Partners Management LP (1519462) Filed by
Heartflow (1464521) Subject
Form SCHEDULE 13G
11/12/2025 7:46 PM
Heartflow (1464521) Issuer
Rogers Campbell (1585724) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2025 7:34 PM
Heartflow (1464521) Issuer
Jones Marie L. (1968991) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2025 7:40 PM
Heartflow (1464521) Issuer
Verghese Vikram (2079946) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2025 7:43 PM
Farquhar John C.M. (1900415) Reporting
Heartflow (1464521) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2025 4:20 PM
Heartflow (1464521) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/12/2025 8:33 AM
Heartflow (1464521) Subject
WELLINGTON MANAGEMENT GROUP LLP (902219) Filed by
Form SCHEDULE 13G
11/05/2025 10:35 AM
FMR LLC (315066) Filed by
Heartflow (1464521) Subject
Form SCHEDULE 13G
09/19/2025 7:31 AM
Heartflow (1464521) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/10/2025 6:30 AM
Heartflow (1464521) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/22/2025 4:13 PM
HCPCIV 1, LLC (2083103) Reporting
HealthCor Partners Fund II, L.P. (1538581) Reporting
HealthCor Partners Fund LP (1408660) Reporting
HealthCor Partners GP, LLC (1519460) Reporting
HealthCor Partners II, L.P. (1643094) Reporting
HealthCor Partners LP (1519456) Reporting
HealthCor Partners Management LP (1519462) Reporting
Heartflow (1464521) Issuer
Form 3
Initial statement of beneficial ownership of securities  
08/22/2025 4:15 PM
HCPCIV 1, LLC (2083103) Reporting
HealthCor Partners Fund II, L.P. (1538581) Reporting
HealthCor Partners Fund LP (1408660) Reporting
HealthCor Partners GP, LLC (1519460) Reporting
HealthCor Partners II, L.P. (1643094) Reporting
HealthCor Partners LP (1519456) Reporting
HealthCor Partners Management LP (1519462) Reporting
Heartflow (1464521) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2025 8:00 PM
Heartflow (1464521) Issuer
Lightcap Jeffrey C (1519465) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2025 8:00 PM
Heartflow (1464521) Issuer
Tansey Casey M (1474322) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2025 8:00 PM
BARABE TIMOTHY C (1237409) Reporting
Heartflow (1464521) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2025 8:00 PM
Heartflow (1464521) Issuer
Jones Marie L. (1968991) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2025 8:01 PM
Heartflow (1464521) Issuer
Rogers Campbell (1585724) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2025 8:01 PM
Heartflow (1464521) Issuer
Verghese Vikram (2079946) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2025 8:01 PM
Farquhar John C.M. (1900415) Reporting
Heartflow (1464521) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2025 8:01 PM
Heartflow (1464521) Issuer
Riley Wayne Joseph (1432895) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2025 8:01 PM
Heartflow (1464521) Issuer
WELDON WILLIAM C (1189019) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2025 8:01 PM
Cullivan Julie A (1713207) Reporting
Heartflow (1464521) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2025 4:08 PM
Heartflow (1464521) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/11/2025 4:17 PM
Heartflow (1464521) Filer
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/11/2025 4:18 PM
Heartflow (1464521) Filer
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/07/2025 11:15 PM
Heartflow (1464521) Filer
Form EFFECT
08/07/2025 8:14 PM
Heartflow (1464521) Issuer
Tansey Casey M (1474322) Reporting
Form 3
Initial statement of beneficial ownership of securities  
08/07/2025 8:14 PM
Heartflow (1464521) Issuer
WELDON WILLIAM C (1189019) Reporting
Form 3
Initial statement of beneficial ownership of securities  
08/07/2025 8:14 PM
Farquhar John C.M. (1900415) Reporting
Heartflow (1464521) Issuer
Form 3
Initial statement of beneficial ownership of securities  
08/07/2025 8:14 PM
Heartflow (1464521) Issuer
Rogers Campbell (1585724) Reporting
Form 3
Initial statement of beneficial ownership of securities  
08/07/2025 8:14 PM
Heartflow (1464521) Issuer
Jones Marie L. (1968991) Reporting
Form 3
Initial statement of beneficial ownership of securities  
08/07/2025 8:15 PM
Heartflow (1464521) Issuer
Lightcap Jeffrey C (1519465) Reporting
Form 3
Initial statement of beneficial ownership of securities  
08/07/2025 8:15 PM
Cullivan Julie A (1713207) Reporting
Heartflow (1464521) Issuer
Form 3
Initial statement of beneficial ownership of securities  
08/07/2025 8:15 PM
Heartflow (1464521) Issuer
Verghese Vikram (2079946) Reporting
Form 3
Initial statement of beneficial ownership of securities  
08/07/2025 8:42 PM
Downing Nicholas (1876110) Reporting
Heartflow (1464521) Issuer
Form 3
Initial statement of beneficial ownership of securities  
08/07/2025 8:46 PM
Bain Capital Life Sciences Fund III, L.P. (1875273) Reporting
Bain Capital Life Sciences III General Partner, LLC (1952106) Reporting
Bain Capital Life Sciences Investors, LLC (1703031) Reporting
BCLS Fund III Investments GP, LLC (1952080) Reporting
BCLS Fund III Investments, LP (1952107) Reporting
Heartflow (1464521) Issuer
Form 3
Initial statement of beneficial ownership of securities  
08/07/2025 8:14 PM
BARABE TIMOTHY C (1237409) Reporting
Heartflow (1464521) Issuer
Form 3
Initial statement of beneficial ownership of securities  
08/07/2025 8:14 PM
Heartflow (1464521) Issuer
Riley Wayne Joseph (1432895) Reporting
Form 3
Initial statement of beneficial ownership of securities  
08/07/2025 9:52 AM
Heartflow (1464521) Filer
Form CERT
08/06/2025 6:42 AM
Heartflow (1464521) Filer
Form S-1/A
08/01/2025 6:32 AM
Heartflow (1464521) Filer
Form S-1/A
(Data available from 1/1/2016 forward)

Heartflow SEC Filings - Frequently Asked Questions

Heartflow (HTFL) has submitted 84+ filings to the SEC since 2017. You can browse the complete history or filter by form type using the tools above.

Heartflow's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results. Key financial data from these reports is available on Heartflow's financial statements page.

The most recent filing was a Form 10-Q submitted on May 14, 2026. This was a quarterly financial update for 2025.

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NASDAQ:HTFL) was last updated on 5/15/2026 by MarketBeat.com Staff.
From Our Partners